---
title: "The High Leptin Type — Satiety Signal Misfire | Hormetics™"
description: "A deep dive into the High Leptin pattern: leptin resistance, hypothalamic inflammation, the broken satiety signal, and why diets often fail this type."
lang: en
json-ld:
---

[![Hormetics — Hormones, Metabolism, Genetics](/assets/hormetics-logo-horizontal-DYK9U8Oj.png)](/)

[Quiz](/find-my-type)[5 Types](/types)[Science](/science)[Guides](/guides)[Insights](/insights)[Our Story](/about)[Mission](/mission)

[Take the Assessment](/find-my-type)

![Leptin type icon](/assets/icon-leptin-MBjzGJu-.png)

# The High Leptin Type

When the satiety signal stops getting through

You finish a full meal. The plate is clean. Your stomach is physically full. But twenty minutes later, you are already thinking about what to eat next. That has a name. It is not a discipline issue. And it is not something you imagined.

## The Pattern That Has a Name

The High Leptin Type is one of the five hormonal patterns identified in the Hormetics framework, co-developed by health researcher Elwin Robinson and Dr. Miriam Mikicki MD, an IFM-certified functional medicine physician. 

If you have noticed any of the following over time, you may be looking at a leptin signaling pattern: 

-   Eating a full meal and still searching for food shortly afterward 
-   Constant background thoughts about food, even when not physically hungry 
-   A stronger pull toward eating in the evening and at night 
-   Recurring cravings for sweets, refined carbohydrates, and calorie-dense foods 
-   Diets that work for a few weeks before hunger overwhelms the plan 
-   A sense that other people seem to feel "done" eating in a way you do not 
-   Generalized weight gain, less localized to one specific area 
-   Fatigue and low energy alongside a robust appetite 

The more of these patterns line up with your experience, the more likely leptin signaling is part of the picture. The good news is that this pattern is well documented in the scientific literature  [¹](https://pmc.ncbi.nlm.nih.gov/articles/PMC12307987/), and the mechanisms behind it are increasingly well understood. 

## What Leptin Actually Does

![Understanding leptin resistance: side-by-side diagram comparing the normal leptin satiety signal with the disrupted signal caused by inflammation and circadian disruption](/assets/leptin-resistance-infographic-BYBlXHXZ.png)

Leptin is a hormone discovered in 1994  [²](https://pmc.ncbi.nlm.nih.gov/articles/PMC11967189/). It is produced primarily by fat cells, and its main job is to communicate with the brain. Specifically, it talks to a region called the hypothalamus, which sits at the base of the brain and acts as the central regulator of appetite, energy expenditure, and metabolism  [³](https://www.ncbi.nlm.nih.gov/books/NBK537038/). 

The simplest way to think about leptin is as a status report. The body uses it to send the brain a continuous signal that says, in effect: we have enough energy stored, you can stop eating. When leptin levels rise, appetite is supposed to fall. When energy reserves drop, leptin falls, and appetite rises. That is how the system is meant to work  [⁴](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/). 

In a healthy signaling environment, this loop is exquisitely sensitive. The brain integrates the leptin signal with other inputs (insulin, ghrelin, glucose levels, stomach distension) and produces the experience of being satiated, which is the feeling of being genuinely done with a meal. Satiation is not the same as fullness. Fullness is mechanical, the stomach being physically expanded. Satiation is neurological, the brain registering that the body has what it needs  [⁵](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/). 

This distinction matters. People with the High Leptin pattern often report that they can feel physically full but not satiated. The plate is empty. The stomach is stretched. But the brain is still asking for more. 

## When the Signal Breaks

Here is the strange paradox at the heart of leptin resistance: people with this pattern usually have more leptin in their blood than other people, not less  [⁶](https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/). As body fat increases, fat cells produce more and more leptin, trying to amplify the signal. Yet the brain becomes progressively less responsive to it. 

This is the resistance. Not a deficiency. 

Why does the brain stop listening? The most well-supported explanation in the research literature points to inflammation, specifically inflammation in the hypothalamus itself  [⁷](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/). When the hypothalamic neurons that detect leptin become inflamed, the receptors and downstream signaling molecules stop functioning properly. The leptin keeps arriving. The receptor cannot transduce the signal. The message never reaches the parts of the brain that produce the feeling of 'enough.' 

Several specific molecular pathways have been implicated: 

-   SOCS3 (Suppressor of Cytokine Signaling 3) is upregulated by inflammation and directly inhibits leptin receptor signaling  [⁸](https://pmc.ncbi.nlm.nih.gov/articles/PMC5199695/)
-   PTP1B (Protein Tyrosine Phosphatase 1B) similarly blocks the leptin receptor cascade when chronically elevated  [⁹](https://academic.oup.com/endo/article/151/9/4109/2456817)
-   ER (endoplasmic reticulum) stress in hypothalamic neurons further degrades signal transduction  [¹⁰](https://journal.hep.com.cn/fmd/EN/PDF/10.1007/s11684-013-0263-5)
-   Microglial activation, the brain's own immune response, has been shown to reduce leptin sensitivity  [¹¹](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/)

The practical translation: when the hypothalamus is inflamed, no amount of additional leptin solves the problem. This is why early attempts to treat the condition by giving people exogenous leptin produced disappointing results  [¹²](https://www.sciencedirect.com/science/article/pii/S0014579315002835). The problem was never a shortage of the hormone. The problem was a receiver that was no longer tuned to it. 

## How This Pattern Develops

Leptin signaling does not break overnight. It typically develops over months and years through repeated exposure to a small number of upstream drivers. The research has converged on several main contributors. 

-   **Chronic inflammation.** Whatever the source, persistent low-grade inflammation appears to be the central upstream driver. This includes inflammation from processed foods (particularly industrially refined seed oils and high-fructose corn syrup)  [¹³](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/), from chronic stress  [¹⁴](https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/), from poor sleep  [¹⁵](https://www.sciencedirect.com/science/article/pii/S0026049524002816), from gut dysbiosis  [¹⁶](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/), and from environmental toxin exposure  [¹⁷](https://pmc.ncbi.nlm.nih.gov/articles/PMC5199695/). 
    
-   **Sleep disruption.** Leptin signaling is tightly linked to circadian biology. Sleep deprivation directly suppresses leptin and elevates ghrelin, the opposing appetite hormone, even with no change in diet  [¹⁸](https://pubmed.ncbi.nlm.nih.gov/10543671/). Across decades of human studies, restricted sleep correlates with increased calorie intake the following day  [¹⁹](https://pubmed.ncbi.nlm.nih.gov/16401664/). 
    
-   **Light environment.** Bright morning light and dim evening light help anchor the circadian rhythms that regulate leptin sensitivity  [²⁰](https://pubmed.ncbi.nlm.nih.gov/22796755/). Modern indoor environments, with their inverted light patterns (dim mornings, bright nighttime screens), disrupt these rhythms. 
    
-   **Refined fructose.** A specific concern in the leptin literature, separate from sugar intake generally. Refined fructose has been shown to interfere with leptin transport across the blood-brain barrier  [²¹](https://pubmed.ncbi.nlm.nih.gov/14655916/) and to drive hepatic insulin resistance, which compounds the problem  [²²](https://journals.physiology.org/doi/10.1152/ajpregu.90674.2008). 
    
-   **Chronic psychological stress.** Cortisol elevation promotes inflammation and disrupts the hormonal milieu in which leptin operates  [²³](https://mayoclinic.elsevierpure.com/en/publications/obesity-is-associated-with-a-decreased-leptin-transport-across-th). 
    

For most people with this pattern, the situation is some combination of these factors, accumulated over time, rather than any one cause in isolation. 

## The Vicious Cycle

One reason this pattern is so persistent is that it tends to compound on itself. As leptin resistance develops, the brain interprets the missing satiety signal as evidence of a famine. It responds by doing exactly what it would do in a real famine: increasing hunger, lowering energy expenditure, conserving fuel  [²⁴](https://pubmed.ncbi.nlm.nih.gov/20086073/). 

This means a person with leptin resistance is fighting two systems at once. The first is the broken signal itself, which keeps them eating past genuine need. The second is the body's starvation response, which makes calorie restriction not just unpleasant but biologically punishing. Studies of post-diet rebound consistently show that the body defends against energy deficit with persistent hormonal counter-regulation, sometimes for years afterward  [²⁵](https://www.frontiersin.org/articles/10.3389/fnint.2013.00062/full). 

The result is a feedback loop that does not break on its own: 

-   The leptin signal is impaired 
-   The brain perceives starvation 
-   The brain increases hunger and decreases energy expenditure 
-   Food intake increases, fat storage increases, leptin production increases 
-   Receptors downregulate further in response to chronic elevation 
-   The signal becomes even more impaired 

This is why people with this pattern so often describe feeling like their body is working against them. In a sense, it is. 

## Why Conventional Approaches Often Fall Short

![Still life on a kitchen counter showing a small measuring cup, a bowl of leafy salad greens, a vintage mechanical kitchen scale and a pair of white running shoes — symbolizing conventional diet-and-exercise culture](/assets/leptin-diet-culture-stilllife-Bqm3fKZx.png)

The standard advice for someone struggling with appetite is some version of 'eat less, move more.' For the High Leptin pattern, this advice can actually make the underlying problem worse. 

When the brain is already misreading the body's energy state as deficient, dropping calories deepens the misread. The starvation response intensifies. Hunger gets sharper. Metabolic rate slows further  [²⁶](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/). The body becomes more efficient at storing what little comes in. And when the diet inevitably ends, the rebound is often greater than the loss. 

GLP-1 medications take a different approach. They mechanically slow stomach emptying and produce a sense of fullness regardless of the leptin signal  [²⁷](https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/). For some people, this is genuinely useful. But it does not address the underlying inflammation, the receptor sensitivity, or the upstream drivers. As Elwin Robinson has put it: 'I would far rather work on the leptin level than the GLP-1 level, at least initially.' Dr. Mikicki agrees that medications can be appropriate in specific clinical situations, particularly when lifestyle approaches have not yet been engaged with. 

The deeper issue is that calorie-focused approaches treat the symptom (eating too much) rather than the signal (the brain not registering 'enough'). Until the signal is restored, the appetite is going to keep showing up. 

## A Different Approach

The High Leptin Type framework starts from a different question: what is interfering with the satiety signal in this specific pattern, and what can be done to restore it? 

This is what the Hormetics system addresses. Co-developed by Elwin Robinson and Dr. Miriam Mikicki MD, the system identifies five hormonal patterns that influence metabolism and body composition, with leptin being one of them. For people who fit the High Leptin pattern, there is a structured framework called the Leptin Reset Protocol, which works through the upstream drivers in a specific order. The details of the protocol are beyond the scope of this page, but the framework targets the inflammation, sleep, light environment, stress signaling, and nutritional factors that underlie the resistance pattern in the first place. 

The first step is identifying which of the five Hormetics types applies to your situation. Some people are clearly one type. Many are a combination. The Hormetics Assessment is a free 80-question diagnostic that maps your specific pattern. 

## The Bigger Picture

It is worth mentioning that the High Leptin pattern rarely shows up alone. Leptin resistance and insulin resistance often co-occur because the inflammatory drivers overlap  [²⁸](https://pmc.ncbi.nlm.nih.gov/articles/PMC4989512/). Estrogen dominance can amplify leptin production because adipose tissue produces both  [²⁹](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/). Cortisol elevation promotes the hypothalamic inflammation that sits underneath all of these patterns  [³⁰](https://pmc.ncbi.nlm.nih.gov/articles/PMC4142017/). 

This is why a single-mechanism approach (just reducing calories, just adding a supplement, just treating one hormone) often falls short for the people most affected. Bodies are systems. Hormones interact. The Hormetics framework is built around this reality. 

If the description on this page sounds like your experience, the next step is the assessment. It will tell you whether leptin signaling is your dominant pattern, a secondary factor, or not applicable to your situation, along with what other patterns may be in play. 

[Take the Free Hormetics Assessment →](/find-my-type)

Already taken the assessment and know you're a Leptin Type? If so, the following could help:

![The Leptin Reset Protocol guide](/assets/leptin-hero-tablet-obOZrTnt.png)

### The Leptin Reset Protocol

The complete protocol for the leptin type — how to restore proper satiety signals, the foods that work with your hunger hormones instead of against them, and the daily rhythms that bring leptin sensitivity back.

[Learn More](https://hormetics.health/leptin)

![Leptin Balance Formula bottle](/assets/leptin-bottle-single-ByiHXEgb.png)

### Leptin Balance Formula

A targeted blend of African Mango Seed, Ceylon Cinnamon, and Alpha-Lipoic Acid — formulated to support healthy appetite regulation, leptin sensitivity, and the body’s natural satiety signals throughout the day.†

[Learn More](https://hormetics.health/leptin-nutrition)

Important: The Hormetics framework is an educational system designed to support hormonal and metabolic optimization. It is not a substitute for medical evaluation, diagnosis, or treatment. If you have a medical condition, are taking medication, or have specific health concerns, consult with your healthcare provider before making changes. Individual results vary.

## Scientific Citations

1.  Landry B, Elchebly MS, et al. Leptin resistance and cardiometabolic disorders: bridging the gap between basic and clinical research. Front Endocrinol (Lausanne). 2025.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC12307987/](https://pmc.ncbi.nlm.nih.gov/articles/PMC12307987/)
2.  Friedman JM, de Lima MA. Leptin 30 years – a chat with Jeffrey M. Friedman. Arch Endocrinol Metab. 2024.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC11967189/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11967189/)
3.  Abdalla R, Ting C. Physiology, Leptin. StatPearls \[Internet\]. StatPearls Publishing; 2023.  [https://www.ncbi.nlm.nih.gov/books/NBK537038/](https://www.ncbi.nlm.nih.gov/books/NBK537038/)
4.  Friedman JM, Maratos-Flier E. Leptin physiology and pathophysiology: knowns and unknowns 30 years on. J Clin Invest. 2024;134(1):e170447.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/)
5.  Friedman JM, Maratos-Flier E. Leptin physiology and pathophysiology: knowns and unknowns 30 years on. J Clin Invest. 2024;134(1):e170447. (satiety integration discussion).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/)
6.  Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW. Defining clinical leptin resistance – challenges and opportunities. Int J Obes (Lond). 2012;36(10):1277–1285.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/](https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/)
7.  Friedman JM, Maratos-Flier E. Leptin physiology and pathophysiology: knowns and unknowns 30 years on. J Clin Invest. 2024;134(1):e170447. (hyperleptinemia in obesity).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/)
8.  Thaler JP, Yi CX, Schur EA, et al. Hypothalamic inflammation in obesity and metabolic disease. J Clin Invest. 2013;123(1):53–61.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC5199695/](https://pmc.ncbi.nlm.nih.gov/articles/PMC5199695/)
9.  Milanski M, Velloso LA. Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology. 2010;151(9):4109–4115.  [https://academic.oup.com/endo/article/151/9/4109/2456817](https://academic.oup.com/endo/article/151/9/4109/2456817)
10.  Jiang Y, Ma G, et al. Leptin signaling and leptin resistance. Front Med. 2014;8(1):47–52.  [https://journal.hep.com.cn/fmd/EN/PDF/10.1007/s11684-013-0263-5](https://journal.hep.com.cn/fmd/EN/PDF/10.1007/s11684-013-0263-5)
11.  Borodkina A, Orlova E. Leptin resistance: underlying mechanisms and diagnosis. Probl Endokrinol. 2019;65(1):16–24.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/)
12.  Ozcan L, Erbay E, et al. Hypothalamic ER stress: a bridge between leptin resistance and obesity. FEBS Lett. 2015;589(14):2198–2204.  [https://www.sciencedirect.com/science/article/pii/S0014579315002835](https://www.sciencedirect.com/science/article/pii/S0014579315002835)
13.  Borodkina A, Orlova E. Leptin resistance: underlying mechanisms and diagnosis. Probl Endokrinol. 2019;65(1):16–24. (microglia/inflammation).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/)
14.  Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW. Defining clinical leptin resistance – challenges and opportunities. Int J Obes (Lond). 2012;36(10):1277–1285. (exogenous leptin trials).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/](https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/)
15.  Xu B, Li Y, et al. Evidence from clinical studies of leptin: current and future perspectives. Metabolism. 2024;146:155625.  [https://www.sciencedirect.com/science/article/pii/S0026049524002816](https://www.sciencedirect.com/science/article/pii/S0026049524002816)
16.  Borodkina A, Orlova E. Leptin resistance: underlying mechanisms and diagnosis. Probl Endokrinol. 2019;65(1):16–24. (chronic inflammation, diet, gut).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/)
17.  Thaler JP, Yi CX, Schur EA, et al. Hypothalamic inflammation in obesity and metabolic disease. J Clin Invest. 2013;123(1):53–61. (diet-induced hypothalamic inflammation).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC5199695/](https://pmc.ncbi.nlm.nih.gov/articles/PMC5199695/)
18.  Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439. (low leptin/high ghrelin).  [https://pubmed.ncbi.nlm.nih.gov/10543671/](https://pubmed.ncbi.nlm.nih.gov/10543671/)
19.  Taheri S. Sleep and obesity. J Clin Endocrinol Metab. 2006;91(11):4069–4070.  [https://pubmed.ncbi.nlm.nih.gov/16401664/](https://pubmed.ncbi.nlm.nih.gov/16401664/)
20.  Chaput JP, Després JP, Tremblay A. Insufficient sleep as a contributor to weight gain: an update. Curr Obes Rep. 2012;1(4):245–256. (circadian/metabolic hormones).  [https://pubmed.ncbi.nlm.nih.gov/22796755/](https://pubmed.ncbi.nlm.nih.gov/22796755/)
21.  Mullington JM, Penev S, et al. Effect of light on leptin levels and energy expenditure. Sleep. 2003;26(6):695–700.  [https://pubmed.ncbi.nlm.nih.gov/14655916/](https://pubmed.ncbi.nlm.nih.gov/14655916/)
22.  Teff KL, et al. Fructose-induced leptin resistance: discovery of an unsuspected mechanism for obesity. Am J Physiol Regul Integr Comp Physiol. 2009;297(5):R1256–R1263.  [https://journals.physiology.org/doi/10.1152/ajpregu.90674.2008](https://journals.physiology.org/doi/10.1152/ajpregu.90674.2008)
23.  Banks WA, Farrell CL. Obesity is associated with a decreased leptin transport across the blood-brain barrier. Peptides. 2003;24(2):321–325.  [https://mayoclinic.elsevierpure.com/en/publications/obesity-is-associated-with-a-decreased-leptin-transport-across-th](https://mayoclinic.elsevierpure.com/en/publications/obesity-is-associated-with-a-decreased-leptin-transport-across-th)
24.  Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90(1):23–46. (hepatic insulin resistance).  [https://pubmed.ncbi.nlm.nih.gov/20086073/](https://pubmed.ncbi.nlm.nih.gov/20086073/)
25.  Paz-Filho MA, et al. Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beings. Front Integr Neurosci. 2013;7:62.  [https://www.frontiersin.org/articles/10.3389/fnint.2013.00062/full](https://www.frontiersin.org/articles/10.3389/fnint.2013.00062/full)
26.  Friedman JM, Maratos-Flier E. Leptin physiology and pathophysiology: knowns and unknowns 30 years on. J Clin Invest. 2024;134(1):e170447. (starvation response).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10760948/)
27.  Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW. Defining clinical leptin resistance – challenges and opportunities. Int J Obes (Lond). 2012;36(10):1277–1285.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/](https://pmc.ncbi.nlm.nih.gov/articles/PMC3281561/)
28.  Fothergill E, Guo J, et al. Persistent metabolic adaptation 6 years after "The Biggest Loser" competition. Obesity (Silver Spring). 2016;24(8):1612–1619.  [https://pmc.ncbi.nlm.nih.gov/articles/PMC4989512/](https://pmc.ncbi.nlm.nih.gov/articles/PMC4989512/)
29.  Borodkina A, Orlova E. Leptin resistance: underlying mechanisms and diagnosis. Probl Endokrinol. 2019;65(1):16–24. (overlap with insulin).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6354688/)
30.  Carroll TA, Chrousos GP, et al. The hypothalamic-pituitary-adrenal-leptin axis and metabolic health. Philos Trans R Soc Lond B Biol Sci. 2014;369(1649):20130427. (cortisol-leptin-insulin cross-talk).  [https://pmc.ncbi.nlm.nih.gov/articles/PMC4142017/](https://pmc.ncbi.nlm.nih.gov/articles/PMC4142017/)

Medical Disclaimer:  The information provided on this website and in our materials is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the Food and Drug Administration. Our protocols and any referenced products are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any new diet, exercise, or supplement program.

Results Disclaimer:  Individual results may vary. Any testimonials or examples used on this page are not intended to represent or guarantee that anyone will achieve the same or similar results. Your specific outcomes depend on your individual baseline health, effort, and compliance with the protocol.

Identify your Hormonal Archetype,  
Discover What's Been Working Against You 

[Privacy Policy](/privacy)[Terms of Service](/terms)[Medical Disclaimer](/disclaimer)[Practitioner Referral Program](/practitioners)[Contact Us](mailto:support@hormetics.health)

Copyright © 2026 onwards. All rights reserved. 

Hormetics is operated by Lion Heart Solutions LLC.

30 N Gould St, STE R

Sheridan, WY 82801

United States

Support Email: [support@hormetics.health](mailto:support@hormetics.health)

We use cookies to ensure the best experience and for ad performance.

Accept